Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Jan 11, 2005 11:09pm
102 Views
Post# 8417156

RE: Tunisia News

RE: Tunisia NewsTOUK... I'm sorry... but how can you possibly be NEGATIVE about a deal of this nature. Here's an international consortium of banks and governments that think enough of Prometic's technology to invest $48mm US in a state of the art production facility. Prometic gets up front dollars, development contracts and royalties on future sales. This is just another in a growing list of great contracts, replicable contracts, that Prometic is stacking up. In this case particularly the nature of the partners virtually assures this moving to fruition and ultimately delivering solid recurring revenue to Prometic. The market is fundamentally a DISCOUNTING MECHANISM. It takes future streams of income and discounts them to Present Value based on their predictability. Prometic is well into the process of leveraging their novel technology platforms into long term licensing an royalty based contracts with tier one clients... hard to believe you can be negative about that. Who cares if the up front money is $2, $5 or $10 million on this deal !... its the 8%,10% or 15 % of $200-$500million US PER YEAR in their sales that is relevant here. We're talking about anywhere between $15 and $50 MILLION PER YEAR from this contract alone to Prometic indefinitely ! Look to the future guys, the future is now for this company.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse